(Q37800300)

23 August 2017

title

Alternative therapies: what role do they have in the management of lupus? (English)

1 reference

23 August 2017

C-T Chou

1

1 reference

23 August 2017

publication date

1 October 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

19

1 reference

23 August 2017

issue

12

1 reference

23 August 2017

page(s)

1425-1429

1 reference

Frequency of systemic lupus erythematosus in different ethnic groups in hawaii

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Systemic lupus erythematosus in Chinese: the Singapore experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Apparent predisposition to systemic lupus erythematosus in Chinese patients in West Malaysia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

High rate of death caused by systemic lupus erythematosus among U. S. residents of Asian descent

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Prevalence and mortality rates of systemic lupus erythematosus and causes of death in SLE patients in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Combination therapy with pulse cyclophosphamide plus pulse methylprednisolone improves long-term renal outcome without adding toxicity in patients with lupus nephritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

The NIH pulse cyclophosphamide regime: the end of an era?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Update on the treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Methotrexate use in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Current treatment of lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

B-cell-directed therapies in systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

B cell depletion therapy in systemic lupus erythematosus: long-term follow-up and predictors of response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Rituximab in systemic lupus erythematosus: A systematic review of off-label use in 188 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Complementary or alternative therapy use and health status in systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

The use of alternative medical therapies in patients with systemic lupus erythematosus. Trination Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Association of complementary or alternative medicine use with quality of life, functional status or cumulated damage in chronic rheumatic diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Use of complementary and alternative medicine by arthritis patients in a university hospital clinic serving rheumatology patients in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Effects of n-3 and n-6 fatty acids on the activities and expression of hepatic antioxidant enzymes in autoimmune-prone NZBxNZW F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

The effects of Chinese herbs on improving survival and inhibiting anti-ds DNA antibody production in lupus mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Immunosuppressive and anti-inflammatory mechanisms of triptolide, the principal active diterpenoid from the Chinese medicinal herb Tripterygium wilfordii Hook. f.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Effects of tripterine on mRNA expression of TGF-beta1 and collagen IV expression in BW F1 mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Prevention of autoantibody formation and prolonged survival in New Zealand Black/New Zealand White F1 mice with an ancient Chinese herb, Ganoderma tsugae

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Herbal medication: potential for adverse interactions with analgesic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Detection of Herba Aristolochia Mollissemae in a patient with unexplained nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Medicinal herbal extracts -- renal friend or foe? Part one: the toxicities of medicinal herbs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Acute renal failure caused by 'cat's claw' herbal remedy in a patient with systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Medicinal herbs: a potential source of toxic metal exposure for man and animals in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Acupuncture for systemic lupus erythematosus: a pilot RCT feasibility and safety study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Effectiveness of acupuncture as adjunctive therapy in osteoarthritis of the knee: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

Electroacupuncture in fibromyalgia: results of a controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0961203310379872

21 January 2018

Identifiers

DOI

10.1177/0961203310379872

1 reference

23 August 2017

1 reference